News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Q Therapeutics, Inc. at Johns Hopkins to Study Use of Neural Glial Cells in Treatment of Myelin Disorders



6/1/2010 2:53:41 PM

SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc. announced today that Piotr Walczak, M.D., of Johns Hopkins University has received notification of a $1,000,000 grant to be awarded by the Maryland Stem Cell Research Fund (MSCRF) which will enable further study of Q’s human neural glial cell product Q-Cells® in preclinical models of demyelinating disease. Dr. Walczak, Principal Investigator, is an Assistant Professor in the Department of Radiology and Radiological Science and a faculty member of the Cellular Imaging Section (CIS) in the Institute for Cell Engineering (ICE) at Johns Hopkins University School of Medicine.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES